Ceredex Value Advisors LLC Has $52.03 Million Stock Holdings in Danaher Corporation $DHR

Ceredex Value Advisors LLC raised its stake in shares of Danaher Corporation (NYSE:DHR) by 5.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 262,420 shares of the conglomerate’s stock after buying an additional 13,043 shares during the period. Danaher comprises about 1.2% of Ceredex Value Advisors LLC’s investment portfolio, making the stock its 15th biggest holding. Ceredex Value Advisors LLC’s holdings in Danaher were worth $52,027,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the 2nd quarter worth about $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the 3rd quarter worth about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $31,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on DHR. Leerink Partners increased their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. HSBC boosted their target price on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Evercore reaffirmed an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a research note on Wednesday, January 28th. Finally, Argus set a $265.00 price objective on shares of Danaher in a report on Wednesday, January 14th. Twenty investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $253.86.

Insider Activity

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.20% of the company’s stock.

Danaher Stock Up 1.7%

DHR stock opened at $198.85 on Tuesday. The stock has a market capitalization of $140.62 billion, a price-to-earnings ratio of 39.45, a price-to-earnings-growth ratio of 2.64 and a beta of 0.93. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a 50-day moving average of $221.89 and a two-hundred day moving average of $215.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business posted $2.14 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio is 25.40%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.